Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,158
  • Shares Outstanding, K 145,112
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,727 K
  • 60-Month Beta 1.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BIOV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +23.08%
on 03/27/24
0.0900 -11.11%
on 04/03/24
+0.0050 (+6.67%)
since 03/18/24
3-Month
0.0400 +100.00%
on 02/01/24
0.1000 -20.00%
on 02/28/24
+0.0350 (+77.78%)
since 01/18/24
52-Week
0.0100 +700.00%
on 12/14/23
0.1000 -20.00%
on 02/28/24
+0.0300 (+60.00%)
since 04/18/23

Most Recent Stories

More News
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
Stocks in play: BioVaxys Technology Corp

Along with SpayVac-for-Wildlife, Inc. jointly announce that SpayVac has partnered with a world leader ...

BIOV.CN : 0.0800 (+14.29%)
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac") jointly announce that SpayVac...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
Stocks in play: BioVaxys Technology Corp

Announced it has received a Notice of Allowance from the United States Patent and Trademark Office for ...

BIOV.CN : 0.0800 (+14.29%)
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance from...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
Stocks in play: BioVaxys Technology Corp

Announced it intends to complete a non-brokered private placement consisting of up to 15,384,615 units ...

BIOV.CN : 0.0800 (+14.29%)
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to complete a non-brokered...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced that the Ontario Securities Commission (the "OSC"), as...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0566 (+3.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0933
2nd Resistance Point 0.0867
1st Resistance Point 0.0833
Last Price 0.0800
1st Support Level 0.0733
2nd Support Level 0.0667
3rd Support Level 0.0633

See More

52-Week High 0.1000
Last Price 0.0800
Fibonacci 61.8% 0.0656
Fibonacci 50% 0.0550
Fibonacci 38.2% 0.0444
52-Week Low 0.0100

See More

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar